Lantheus Holdings, Inc. (LNTH)
Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagnostic portfolio features several key products: DEFINITY, a microbubble ultrasound contrast agent for cardiac evaluations; TechneLite, a technetium generator essential for nuclear medicine; Xenon-133, used to assess pulmonary function; Neurolite, which helps identify stroke-damaged areas in the brain; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 for detecting cardiovascular disease; and Gallium-67, utilized in identifying infections and cancerous tumors. They also offer the Automated Bone Scan Index, a tool for quantifying prostate cancer burden from bone scans; PYLARIFY, designed for visualizing lymph nodes, bone, and soft tissue metastases to detect recurrent or metastatic prostate cancer; and Cobalt (Co 57), a non-pharmaceutical radiochemical. In the therapeutic space, Lantheus provides AZEDRA, a radiopharmaceutical treatment for both adult and pediatric patients, and RELISTOR, a medication addressing opioid-induced constipation. The company's robust development pipeline includes promising innovations such as flurpiridaz F 18, an agent for assessing myocardial blood flow; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in both children and adults; PYLARIFY AI, an AI-powered medical device software for standardized quantitative analysis of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. Lantheus serves a diverse client base, including radiopharmacies, distributors, integrated delivery networks, hospitals, clinics, and group medical practices. They foster strategic collaborations with notable industry partners such as NanoMab Technology Limited, Bausch Health Companies, Inc., GE Healthcare Limited, Curium, Bayer AG, CytoDyn Inc., ROTOP, FUJIFILM, Regeneron Pharmaceuticals, Inc., and POINT Biopharma US Inc. Established in 1956, Lantheus Holdings, Inc. maintains its corporate headquarters in North Billerica, Massachusetts.
Sector: In Vitro & In Vivo Diagnostic Substances
Industry: Drug Manufacturers - Specialty & Generic
Lantheus Holdings, Inc.
NASDAQ:LNTHHealthcare · Drug Manufacturers - Specialty & Generic
+0.14%$100.46
AH$100.46+0.00%vs close
Mkt Cap$6.56B
Float63.82M
O/S65.3M
Vol
$ Vol
RVOL
Inst Own-
SI5.7%
Earnings
Dilution
Financials Summary
Revenue$1.54B
Net Income$233.56M
Total Assets$2.23B
Free Cash Flow$354.05M
Debt & Equity
Debt 36%
Equity 64%
Total Debt$619.43M
Total Equity$1.09B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in LNTH's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$2.23B
Liabilities$1.14B
Accounts Receivable$358.64M
Accounts Payable$42.91M
Inventory$64.67M
PP&E (Net)$163.69M
Goodwill$239.52M
Intangible Assets$722.78M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $1.54B | $1.53B | $1.3B | $935.06M | $425.21M | $339.41M | $347.34M | $343.37M | $331.38M | $301.85M | $293.46M | $301.6M | $283.67M | $288.11M | $356.29M |
| YoY Growth | 0.5% | 18.3% | 38.6% | 119.9% | 25.3% | -2.3% | 1.2% | 3.6% | 9.8% | 2.9% | -2.7% | 6.3% | -1.5% | -19.1% | - |
| Cost of Revenue | $599.66M | $545.62M | $586.89M | $353.36M | $237.51M | $200.65M | $172.53M | $168.49M | $169.24M | $164.07M | $157.94M | $176.08M | $206.31M | $212.91M | $261.08M |
| Gross Profit | $941.95M | $988.29M | $709.54M | $581.7M | $187.69M | $138.76M | $174.81M | $174.88M | $162.13M | $137.78M | $135.52M | $125.52M | $77.36M | $75.2M | $95.22M |
| Gross Margin | 61.1% | 64.4% | 54.7% | 62.2% | 44.1% | 40.9% | 50.3% | 50.9% | 48.9% | 45.6% | 46.2% | 41.6% | 27.3% | 26.1% | 26.7% |
| Research and Development | $177.31M | $168.1M | $77.71M | $311.68M | $44.97M | $32.79M | $20.02M | $17.07M | $18.13M | $12.2M | $14.36M | $13.67M | $30.46M | $40.6M | $40.95M |
| Selling, General, and Administrative | $453.81M | $371.63M | $267.19M | $233.83M | $218.82M | $110.17M | $103.13M | $93.33M | $92.16M | $75.37M | $78.63M | $72.43M | $68.26M | $69.96M | $71.55M |
| Other | $0 | -$8.41M | $0 | $0 | -$15.26M | $0 | $0 | $0 | $0 | $220K | -$89K | $3K | $0 | $0 | $205K |
| Total Operating Expenses | $631.12M | $531.31M | $344.9M | $545.51M | $248.52M | $142.96M | $123.15M | $110.4M | $110.28M | $87.58M | $92.99M | $86.1M | $98.72M | $110.56M | $112.5M |
| Operating Income (EBIT) | $310.83M | $456.98M | $364.64M | $36.2M | -$60.83M | -$4.2M | $51.66M | $64.49M | $51.85M | $56.59M | $42.53M | $39.42M | -$18.89M | -$750K | -$17.28M |
| Operating Margin | 20.2% | 29.8% | 28.1% | 3.9% | -14.3% | -1.2% | 14.9% | 18.8% | 15.6% | 18.7% | 14.5% | 13.1% | -6.7% | -0.3% | -4.8% |
| Interest Expense | $19.75M | $19.67M | $20.02M | $7.18M | $7.75M | $9.48M | $13.62M | $17.41M | $18.41M | $26.62M | $38.72M | $42.29M | $42.91M | $42.01M | $37.66M |
| Interest Income | $23.39M | $36.84M | $19.64M | $2.61M | $45K | $238K | $686K | $167K | $18K | $0 | $0 | $0 | $104K | $252K | $333K |
| Other Income (Expense) | $2.96M | -$26M | $46.3M | -$9.48M | -$14.21M | -$7.28M | -$23.03M | -$14.94M | -$12.21M | -$28.29M | -$54.31M | -$41.78M | -$41.65M | -$7.19M | -$35.9M |
| Income Before Tax (EBT) | $313.79M | $430.98M | $410.94M | $26.72M | -$75.04M | -$11.48M | $28.63M | $49.55M | $39.64M | $28.29M | -$11.78M | -$2.37M | -$60.54M | -$42.56M | -$53.18M |
| Income Tax Expense | $80.23M | $118.53M | $84.28M | -$1.35M | -$3.76M | $1.99M | -$3.04M | $9.03M | -$83.75M | $1.53M | $2.97M | $1.2M | $1.01M | -$555K | $84.08M |
| Net Income | $233.56M | $312.44M | $326.66M | $28.07M | -$71.28M | -$13.47M | $31.67M | $40.52M | $123.39M | $26.76M | -$14.75M | -$3.56M | -$61.55M | -$42M | -$137.26M |
| Net Income Margin | 15.2% | 20.4% | 25.2% | 3.0% | -16.8% | -4.0% | 9.1% | 11.8% | 37.2% | 8.9% | -5.0% | -1.2% | -21.7% | -14.6% | -38.5% |
| Supplementary Data | |||||||||||||||
| EPS | 3.46 | 4.52 | 4.79 | 0.41 | -1.06 | -0.25 | 0.81 | 1.06 | 3.31 | 0.84 | -0.60 | -0.20 | -3.40 | -2.36 | -7.61 |
| Diluted EPS | 3.41 | 4.36 | 4.65 | 0.40 | -1.06 | -0.25 | 0.79 | 1.03 | 3.17 | 0.82 | -0.60 | -0.20 | -3.34 | -2.32 | -7.61 |
| Weighted Average OS | 67.49M | 69.20M | 68.27M | 68.49M | 67.49M | 54.13M | 38.99M | 38.23M | 37.28M | 32.04M | 24.44M | 17.80M | 18.08M | 17.79M | 18.03M |
| EBITDA | $403.64M | $515.27M | $491M | $81.83M | -$25M | $22.69M | $55.62M | $80.88M | $77.28M | $73.17M | $46.59M | $58.17M | $7.53M | $26.86M | $17.74M |
| EBITDA Margin | 26.2% | 33.6% | 37.9% | 8.8% | -5.9% | 6.7% | 16.0% | 23.6% | 23.3% | 24.2% | 15.9% | 19.3% | 2.7% | 9.3% | 5.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $359.12M | $912.81M | $713.66M | $415.65M | $98.51M | $79.61M | $92.92M | $113.4M | $76.29M | $51.18M | $28.6M | $19.74M | $18.58M | $33.32M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $359.12M | $912.81M | $713.66M | $415.65M | $98.51M | $79.61M | $92.92M | $113.4M | $76.29M | $51.18M | $28.6M | $19.74M | $18.58M | $33.32M |
| Accounts Receivable | $358.64M | $321.26M | $284.29M | $213.4M | $89.34M | $54M | $43.53M | $43.75M | $40.26M | $36.82M | $37.29M | $41.79M | $39.23M | $39.58M |
| Inventory | $64.67M | $68.03M | $64.03M | $35.48M | $35.13M | $35.74M | $29.18M | $33.02M | $26.08M | $17.64M | $15.62M | $15.58M | $18.31M | $18.05M |
| Other Current Assets | $117.53M | $9.13M | $7.41M | $205K | $2.71M | $5.69M | $7.28M | $5.24M | $5.22M | $5.18M | $8.59M | $4.37M | $3.12M | $5.59M |
| Total Current Assets | $899.96M | $1.33B | $1.09B | $677.62M | $235.79M | $184.22M | $172.91M | $195.41M | $147.85M | $110.82M | $90.1M | $81.23M | $79.25M | $96.54M |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $163.69M | $212.88M | $192.02M | $141.2M | $125.56M | $138.61M | $116.5M | $107.89M | $93M | $94.19M | $86.52M | $96.01M | $97.65M | $109.57M |
| Goodwill | $239.52M | $61.19M | $61.19M | $61.19M | $61.19M | $58.63M | $15.71M | $15.71M | $15.71M | $15.71M | $15.71M | $15.71M | $15.71M | $15.71M |
| Intangible Assets | $722.78M | $161.76M | $151.99M | $315.29M | $348.51M | $376.01M | $7.34M | $9.13M | $11.8M | $15.12M | $29.63M | $29.61M | $36.47M | $69.04M |
| Long-Term Investments | $42.21M | $39.49M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $74K | $7.35M | $9.64M | $0 |
| Deferred Tax Assets | $109.2M | $170.23M | $150.2M | $110.65M | $62.76M | $70.15M | $71.83M | $81.45M | $87.01M | $0 | -$74K | $328K | $15K | $0 |
| Other Long-Term Assets | $50.04M | $8.15M | $9.94M | $15.32M | $29.97M | $42.19M | $21.63M | $30.23M | $28.49M | $20.06M | $20.41M | $19.32M | $22.58M | $33.79M |
| Total Long-Term Assets | $1.33B | $653.71M | $565.33M | $643.64M | $627.99M | $685.6M | $233.01M | $244.42M | $236.01M | $145.08M | $152.28M | $168.34M | $182.07M | $228.11M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.23B | $1.98B | $1.65B | $1.32B | $863.78M | $869.82M | $405.92M | $439.83M | $383.86M | $255.9M | $242.38M | $249.57M | $261.31M | $324.65M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $42.91M | $34.56M | $41.19M | $20.56M | $20.79M | $16.28M | $18.61M | $17.95M | $17.46M | $18.94M | $11.66M | $15.66M | $18.1M | $18.95M |
| Short-Term Debt | $738K | $974K | $823K | $354K | $11.64M | $20.7M | $10.14M | $2.75M | $2.75M | $3.65M | $3.65M | $8M | $8M | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $30.01M | $23.79M | $19.3M | $18.7M | $132K | $3.98M | $7.32M |
| Other Current Liabilities | $104.28M | $60.25M | $48.24M | $155.65M | $28.08M | $25.59M | $17.05M | $16.09M | $12.07M | $8.94M | $8.39M | $11.87M | $13.92M | $6M |
| Total Current Liabilities | $333.42M | $240.53M | $187.35M | $247.7M | $90.5M | $80.5M | $66.11M | $52.76M | $46.75M | $43.84M | $35.72M | $48.53M | $55.63M | $56.07M |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $568.68M | $565.28M | $561.67M | $557.71M | $163.12M | $197.7M | $183.93M | $263.71M | $265.39M | $274.46M | $349.86M | $399.28M | $399.04M | $398.82M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7.79M | $6.74M | $5.78M |
| Long-Term Deferred Tax Liabilities | $54.25M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $247K | $12K | $435K |
| Other Long-Term Liabilities | $131.24M | $33.34M | $31.78M | $43.26M | $129.18M | $59.91M | $41.09M | $52.37M | $48.42M | $44.12M | $42.09M | $32.99M | $35.41M | $36.65M |
| Total Long-Term Liabilities | $804.18M | $651.8M | $647.91M | $626.41M | $308.85M | $275.11M | $225.21M | $316.07M | $313.82M | $318.57M | $391.95M | $440.31M | $441.2M | $441.69M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.14B | $892.33M | $835.26M | $874.11M | $399.35M | $355.62M | $291.32M | $368.83M | $360.57M | $362.41M | $427.67M | $488.84M | $496.83M | $497.76M |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $718K | $709K | $699K | $689K | $677K | $669K | $393K | $385K | $378K | $367K | $303K | $51K | $51K | $50K |
| Retained Earnings | $679.5M | $445.94M | $133.5M | -$193.16M | -$221.22M | -$149.95M | -$136.47M | -$168.14M | -$209.01M | -$332.4M | -$359.16M | -$344.41M | -$340.85M | -$279.3M |
| Comprehensive Income & Other | -$1.31M | -$1.61M | -$1.04M | -$1.26M | -$485K | -$2.05M | -$960K | -$1.11M | -$1.03M | -$947K | -$1.99M | -$1.63M | -$394K | $1.33M |
| Other Stockholders' Equity | $409.57M | $641.36M | $681.69M | $639.62M | $684.99M | $663.48M | $250.68M | $238.76M | $231.93M | $225.51M | $173.57M | $105.09M | $105.28M | $106.14M |
| Total Equity | $1.09B | $1.09B | $815.89M | $447.15M | $464.44M | $514.21M | $114.6M | $71M | $23.29M | -$106.52M | -$185.29M | -$239.27M | -$235.52M | -$173.1M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.23B | $1.98B | $1.65B | $1.32B | $863.78M | $869.82M | $405.92M | $439.83M | $383.86M | $255.9M | $242.38M | $249.57M | $261.31M | $324.65M |
| Supplementary Data | ||||||||||||||
| Total Debt | $619.43M | $619.44M | $616.95M | $583.51M | $191.31M | $235.9M | $194.4M | $266.46M | $268.14M | $278.11M | $353.51M | $407.28M | $407.04M | $398.82M |
| Net Debt | $260.31M | -$293.38M | -$96.71M | $167.86M | $92.8M | $156.29M | $101.48M | $153.06M | $191.85M | $226.93M | $324.91M | $387.54M | $388.46M | $365.5M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||||
| Net Income | $233.56M | $312.44M | $326.66M | $28.07M | -$71.28M | -$13.47M | $31.67M | $40.52M | $123.39M | $26.76M | -$14.75M | -$3.56M | -$61.55M | -$42M | -$137.26M |
| Depreciation & Amortization | $70.1M | $64.62M | $60.04M | $47.93M | $42.29M | $24.69M | $13.38M | $13.93M | $19.23M | $18.26M | $19.65M | $18.25M | $25.16M | $27.4M | $32.76M |
| Deferred Income Tax | $21.59M | -$24.79M | -$55.63M | -$50.94M | $3.65M | -$724K | $7.2M | $6.13M | -$92.57M | $365K | $868K | $159K | -$651K | $438K | $81.74M |
| Stock-Based Compensation | $0 | $76.39M | $50.51M | $29.26M | $15.93M | $14.07M | $12.49M | $8.72M | $5.93M | $2.52M | $2M | $1.03M | $578K | $1.24M | -$969K |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | -$17.89M | -$37.69M | -$68.64M | -$128.46M | -$33.1M | -$7.46M | $156K | -$3.98M | -$3.41M | -$1.06M | -$14K | -$3.56M | $2.63M | -$1.44M | $9.47M |
| Inventory | -$9.37M | -$2.67M | -$36.22M | -$7.51M | -$3.55M | -$8.46M | $1.99M | -$8.69M | -$9.62M | -$3.63M | -$2.61M | $1.5M | -$4.74M | -$6.9M | -$22.29M |
| Accounts Payable | -$2.49M | -$8.8M | $17.19M | $301K | $5.42M | -$4.22M | $3.23M | -$2.89M | $604K | $5.7M | -$1.68M | -$4.05M | -$1.15M | -$2.23M | -$905K |
| Other Working Capital | -$14.49M | $51.21M | -$83.53M | $60.6M | $16.07M | -$2.22M | $3.67M | $1.59M | $4.11M | $1.07M | -$3.93M | -$5.73M | -$8.2M | $5.76M | -$256K |
| Total Working Capital Change | -$44.23M | $2.05M | -$171.2M | -$75.06M | -$15.15M | -$22.36M | $9.05M | -$13.97M | -$8.32M | $2.09M | -$8.23M | -$11.84M | -$11.46M | -$4.82M | -$13.99M |
| Other Non-Cash Items | $109.12M | $114.04M | $94.88M | $302.53M | $78.48M | $14.19M | $6.59M | $5.87M | $7.12M | -$362K | $22.22M | $7.55M | $32.36M | $17.36M | $60.92M |
| Net Cash from Operating | $390.14M | $544.75M | $305.26M | $281.78M | $53.92M | $16.4M | $80.38M | $61.19M | $54.78M | $49.64M | $21.76M | $11.59M | -$15.57M | -$372K | $23.21M |
| Investing Activities | |||||||||||||||
| Capital Expenditures | -$41.5M | -$79.63M | -$46.55M | -$18.35M | -$12.14M | -$12.47M | -$22.06M | -$20.13M | -$17.54M | -$7.4M | -$13.15M | -$8.14M | -$5.01M | -$7.92M | -$7.69M |
| Acquisitions | -$575.67M | -$80.91M | $0 | $0 | $0 | $17.56M | $0 | $1M | $1.23M | $10.61M | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$10M | -$83.25M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $74K | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $17.77M | $52.49M | -$258.2M | $15.82M | -$10M | $0 | $1M | $1.23M | $10.68M | $0 | $455K | $1.53M | -$225K | $0 |
| Net Cash from Investing | -$627.17M | -$226.01M | $5.94M | -$276.55M | $3.68M | -$4.91M | -$22.06M | -$19.13M | -$16.31M | $3.28M | -$13.15M | -$7.68M | -$3.48M | -$8.14M | -$7.69M |
| Financing Activities | |||||||||||||||
| Debt Repaid | $1.11M | $318K | $717K | -$382.37M | $43.35M | $15.49M | $75.92M | $2.86M | $12.38M | $78.73M | $51.21M | $71K | $1.31M | $1.53M | -$152.25M |
| Common Stock Issuance | $10.88M | $3.45M | $1.93M | $1.38M | $767K | $683K | $573K | $428K | $187K | $50.9M | $73.54M | $13K | $400K | $551K | $0 |
| Common Stock Repurchases | -$300.02M | -$100M | $0 | -$75M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$106K | -$174K | -$44.09M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$123K | -$3.52M | -$101.12M |
| Other Financing Activities | -$26.34M | -$21.67M | -$14.28M | $2.95M | $3.25M | -$7.05M | -$1.28M | -$2.23M | $320K | -$2.39M | -$7.02M | $13K | $0 | -$442K | -$9.24M |
| Net Cash from Financing | -$316.58M | -$118.54M | -$13.06M | $311.69M | -$39.33M | -$21.86M | -$78.88M | -$4.67M | -$13.45M | -$30.22M | $999K | -$2.3M | $5.61M | -$5.11M | -$2.21M |
| Forex Effect | -$49K | -$998K | -$93K | -$335K | -$310K | $152K | $76K | -$282K | $94K | -$124K | -$753K | -$450K | -$1.3M | $649K | -$134K |
| Net Change in Cash | -$553.66M | $199.2M | $298.04M | $316.59M | $17.96M | -$10.22M | -$20.48M | $37.11M | $25.11M | $22.58M | $8.86M | $1.16M | -$14.74M | -$12.98M | $13.17M |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | $390.14M | $544.75M | $305.26M | $281.78M | $53.92M | $16.4M | $80.38M | $61.19M | $54.78M | $49.64M | $21.76M | $11.59M | -$15.57M | -$372K | $23.21M |
| Capital Expenditure | -$36.09M | -$51.63M | -$46.55M | -$18.35M | -$12.14M | -$12.47M | -$22.06M | -$20.13M | -$17.54M | -$7.4M | -$13.15M | -$8.14M | -$5.01M | -$7.92M | -$7.69M |
| Free Cash Flow | $354.05M | $493.13M | $258.7M | $263.43M | $41.78M | $3.92M | $58.32M | $41.06M | $37.23M | $42.24M | $8.61M | $3.45M | -$20.58M | -$8.29M | $15.52M |
| Cash at Beginning | $914.49M | $715.28M | $417.24M | $100.65M | $82.69M | $92.92M | $113.4M | $76.29M | $51.18M | $28.6M | $19.74M | $18.58M | $33.32M | $46.3M | $33.13M |
| Cash at End | $360.83M | $914.49M | $715.28M | $417.24M | $100.65M | $82.69M | $92.92M | $113.4M | $76.29M | $51.18M | $28.6M | $19.74M | $18.58M | $33.32M | $46.3M |